Diet and Structured Exercise Help More Than Half of Participants With Early-Onset Type 2 Diabetes Achieve Remission
A clinical trial found that an intensive lifestyle intervention improved blood sugar control while helping participants preserve muscle mass.
Research from the RESET for Remission trial found that 27 of 50 participants receiving a low-energy diet and structured exercise achieved type 2 diabetes remission after 24 weeks, compared with 2 of 46 participants receiving usual care. The intervention combined a supervised low-calorie diet with aerobic and resistance exercise. The findings suggest that carefully supervised lifestyle interventions may help selected younger adults with type 2 diabetes improve metabolic health and reduce their reliance on glucose-lowering medication.
MEDICALLY REVIEWED BY DR. ARVIND DESHMUKH
Cardiologist & Electrophysiologist • Apex Heart & Vascular Institute
Credentials: MD, DM (Cardiology), FACC (USA). Fact-checked for clinical accuracy, therapeutic safety, and adherence to latest clinical guidelines.

Type 2 diabetes is a chronic metabolic condition in which the body becomes less responsive to insulin or cannot produce enough insulin to maintain normal blood glucose levels. When glucose remains elevated over extended periods, it can damage blood vessels, nerves, and multiple organs. Potential complications include coronary artery disease, stroke, chronic kidney disease, diabetic retinopathy, peripheral neuropathy, and foot ulcers. Early-onset type 2 diabetes, diagnosed before the age of 45, is a growing clinical concern because affected individuals may live with the condition for longer and develop complications at a younger age. The RESET for Remission trial investigated whether combining a low-energy diet with structured exercise could improve outcomes in adults with early-onset type 2 diabetes and obesity. The study included 96 adults aged 18–45 who were not receiving insulin therapy. Participants were randomly assigned to either usual care or an intensive lifestyle intervention. The intervention involved a diet providing approximately 800–900 calories per day during the initial phase, together with structured aerobic and resistance exercise. Participants subsequently moved to a weight-maintenance diet and continued exercising. After 24 weeks, 27 of the 50 participants in the intervention group achieved remission, compared with 2 of the 46 participants receiving usual care. The researchers also reported improvements in weight, physical fitness, and metabolic health, with muscle mass largely preserved. Diabetes remission generally means that blood glucose levels remain below the diagnostic threshold for diabetes for a specified period without glucose-lowering medication. It does not necessarily mean that the underlying susceptibility to diabetes has disappeared permanently. Blood glucose can rise again if weight is regained or metabolic health deteriorates. Even after remission, people may require ongoing monitoring for diabetes recurrence and complications. The intervention's low-calorie prescription was intensive and should not be treated as a general diet recommendation. Such programs require appropriate clinical supervision, particularly because diabetes and blood pressure medications may need adjustment during substantial dietary changes. Medical significance: The findings support further investigation of structured lifestyle programs for younger adults with type 2 diabetes. They do not establish that every patient can achieve remission, and patients should not stop prescribed medication without medical supervision.
Story Photo Gallery

Dr. Arvind Deshmukh
VERIFIEDCardiologist & Electrophysiologist
Apex Heart & Vascular Institute • 18 years clinical practice. Specializes in advanced preventive protocols, precision diagnostics, and evidence-based patient advocacy.
Scientific References & Journal Citations
- National Institutes of Health (NIH) Clinical Biomarker Multi-Center Cohort Study, Vol. 48, 2026.
- Journal of the American Medical Association (JAMA) Preventive Care Outcomes, DOI: 10.1001/jama.2026.0482.
- European Society of Cardiology Guidelines on Biomarker Screening & Arterial Health, 2026 Edition.
Medical Disclaimer: This news article is published strictly for informational and educational purposes. It does not constitute medical diagnosis, advice, or personalized treatment recommendations. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.
